Semaglutide in Treatment of Obesity

NCT06604624 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

462

Enrollment

INDUSTRY

Sponsor class

Conditions

Weight Management

Interventions

DRUG: HD1916
DRUG: semaglutide

Sponsor

CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.